Ayhan Yunus Emre, Turgut Namigar
Prof. Dr. Cemil Taşcıoğlu City Hospital, Department of Clinical Pharmacy, Istanbul, Türkiye.
Department of Anaesthesiology and Reanimation, Prof. Dr. Cemil Taşcıoğlu City Hospital, University of Health Sciences, Istanbul, Türkiye.
J Pharm Pharm Sci. 2025 Mar 4;28:14067. doi: 10.3389/jpps.2025.14067. eCollection 2025.
This study aims to enhance adherence to the guideline through an educational program focused on reducing inappropriate use of stress ulcer prophylaxis (SUP) and cost savings in the intensive care unit (ICU).
This study was designed as a nonrandomized, controlled, prospective study created according to the pre-education (PreEd) and post-education (PostEd) evaluation model and conducted between January and July 2024. The appropriateness of SUP uses for the indication was evaluated according to the Sociedade Portuguesa de Cuidados (SPC) SUP guideline. Adherence rates to the SPC SUP guideline and the costs associated with nonadherence were evaluated.
495 patients were included in the study, 244 in PreEd and 251 in PostEd. 58.2% of the patients were male, and the hospitalization was mainly for medical reasons (59.6%). The mean ± SD rate of patients with appropriate SUP indication was 38.3 ± 41.6% in PreEd and 47.8 ± 42.8% in PostEd (p = 0.005). The total costs of inappropriate indication and proton pump inhibitor use in PreEd and PostEd were 272 dollars and 246 dollars, respectively (p = 0.007). Accordingly, when inappropriate SUP agent use was calculated per patient in both periods, the total cost saving was 34 dollars.
Inappropriate SUP use is common in the ICU. Adequate adherence to guidelines and proactive involvement of clinical pharmacists may reduce inappropriate SUP use and associated costs.
本研究旨在通过一项教育计划提高对指南的依从性,该计划侧重于减少重症监护病房(ICU)中应激性溃疡预防(SUP)的不当使用并节省成本。
本研究设计为一项非随机、对照、前瞻性研究,根据教育前(PreEd)和教育后(PostEd)评估模型开展,于2024年1月至7月进行。根据葡萄牙护理协会(SPC)的SUP指南评估SUP用于该适应症的合理性。评估对SPC SUP指南的依从率以及与不依从相关的成本。
495例患者纳入研究,其中PreEd组244例,PostEd组251例。58.2%的患者为男性,住院主要是由于医疗原因(59.6%)。PreEd组有适当SUP适应症的患者平均±标准差率为38.3±41.6%,PostEd组为47.8±42.8%(p = 0.005)。PreEd组和PostEd组中不当适应症和使用质子泵抑制剂的总成本分别为272美元和246美元(p = 0.007)。因此,当计算两个时期每位患者不当使用SUP药物的情况时,总成本节省了34美元。
ICU中SUP的不当使用很常见。充分遵守指南以及临床药师的积极参与可能会减少SUP的不当使用及相关成本。